Centene (STU:QEN) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:QEN Centene Corp STU:QEN
74 GF Score
Price €55.98
GF Value €72.16
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Centene FFO?

FFO (Funds from operations) only applies to REITs.

STU:QEN
74GF Score
Centene Corp STU:QEN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Centene (STU:QEN) Overvalued in 2026?

Based on GuruFocus' analysis, Centene stock appears to be undervalued. The current stock price of €55.98 is trading 22.4% below its estimated GF Value™ of €72.16. GuruFocus considers Centene to be Modestly Undervalued.

Key valuation signals for STU:QEN:

  • FFO:
  • GF Value™: €72.16 vs. price of €55.98 (22.4% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the STU:QEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Centene Business Description

Address 7700 Forsyth Boulevard, St. Louis, MO, USA, 63105
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
74GF Score

Get the complete analysis for STU:QEN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.98
Price
€72.16
GF Value